| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.4M | +405.4% |
| Cost of Revenue | $624K | +1100.0% |
| Gross Profit | $771K | +244.2% |
| R&D Expense | $2.3M | +18.7% |
| SG&A Expense | $6.0M | -23.0% |
| Operating Income | -$7.6M | +20.6% |
| Pre-tax Income | -$7.9M | +11.3% |
| Income Tax | $0 | — |
| Net Income | -$7.9M | +11.3% |
| EPS (Basic) | -$0.23 | +34.3% |
| EPS (Diluted) | -$0.23 | +34.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $350K | +714.0% |
| Current Assets | $915K | -62.2% |
| Total Assets | $9.4M | +4.5% |
| Current Liabilities | $6.4M | +87.2% |
| Total Liabilities | $7.5M | +113.1% |
| Stockholders' Equity | $1.9M | -65.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$4.9M | +34.4% |
| Investing Cash Flow | -$1.9M | -62.6% |
| Financing Cash Flow | $6.1M | -25.0% |